Delivery Order SPE2DB20D3101-SPE2DB25FRGR3

Award Date 4/11/25
Potential Completion Date 4/14/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,224.04, is a delivery order for the medication Repatha 140 mg/ml SureClick. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,650.27, is a delivery order for the medication Repatha (140 mg/mL SureClick) and has a period of performance through April 16, 2025. The contract is not set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,617.06, is for the delivery of the medication Repatha 140 mg/mL SureClick. It is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,082.84, is for the delivery of the medication Repatha (140 mg/mL SureClick) and has a period of performance through April 14, 2025. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,944.64, is for the delivery of Repatha 140 mg/mL SureClick medication. It is a firm fixed price delivery order contract with an ultimate completion date of April 15, 2025. The contract is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,198.85 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.82, is for the delivery of Repatha 140 mg/ml SureClick medication. It is a firm fixed-price delivery order contract that runs through April 7, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,577.97 firm-fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of March 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,195.86 firm-fixed-price delivery order covers the supply of the drug Repatha (140 mg/mL) and has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,248.15 firm fixed-price contract is for the supply of Repatha 140 mg/ml SureClick, a prescription medication. The delivery order has a completion date of May 19, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRGR3
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,601.54, is a delivery order for the medication Repatha 140 mg/ml SureClick, with an ultimate completion date of April 14, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award referenced in this summary is a task order issued under that broader IDC. No set-aside designation was used for this specific contract.

Generated 7/11/25, 10:09 AM